@SvallOh how your sentiment has changed since this your initial post below
I think Antisense has burned through more than 50m in funds since inception and doesn't have a single product to its name, a quick look at balance sheet would reveal that, and might be impacting how people see this companyAround 20 years ago the stock was closer to $1.50
10 years ago closer to 40cThis is a classic example of a zombie biotech - burning through funds continually with no improvement in share price or profits to speak of.
Question is, will it stay this way, or will the company's fortunes reverse?Also why aren't any management holding significant amounts of stock? Doesn't inspire much confidence if you ask me.Criticisms welcomeSvall
It would now appear you have your fill now and willing to get stuck into some of our longer term holders Akki in particular for his thoughts
and all of a sudden you have turned into a
BIOTECH SPECIALIST that is actually working in the
biotech field yet you found it pertinent to call ANP
( Quote)
a classic example of a zombie biotech LOLThen follow up down the track with
Also I'd say going from nothing to good phase 2 results inside 2 years isn’t "plodding along slowly"
Taken from the FDA site
Today, the path from initial demonstration that a molecule may have therapeutic potential to the production of an approved drug involves pre-clinical testing, complex clinical trials in humans, and post-trial regulatory approval by the FDA. For drugs, this process can take 10 to 15 years and cost millions of dollars
This board have been going for 20yrs now and we are still years away from market ???
IF THATS NOT PLODDING I DONT KNOW WHAT IS And you go on to say to a poster
Have you even stepped foot in a lab or biotech office in your life? Because it sure as hell doesn't sound like itREALLYIt would appear that even you are more aware of the goings on in the FDA than our CEO in Mark Diamond
In my recent post i quoted as per below
The simple fact is we will not be allocated a voucher until commercialization and there is no guarantee we will be allocated one at that timeSvall to which you replied
Actually the voucher is guaranteed if ATL1102 gains approval just fyiWell Svall
FYIPlease take note
Mark Diamonds own words not mine
FYI“The designation doesn’t guarantee a voucher, you still need to meet the eligibility criteria,” Mr Diamond says. “But having the designation gives you confidence the FDA believes the disease you are treating meets their conditions.”So it would appear that my statement was correct Svall
I wonder just how much research the people that give the likes of yourself TU actually do
If you are so knowledgeable Svall and you are in a smaller Biotech than ANP we have an AGM coming up in the next few weeks, maybe its time to step up
Please Svall throw your hat in the ring to be nominated as our new CEO you will get my vote
Because lets face it Svall with your experience i coudnt really see you performing much worse than the leader of this
ZOMBIE BIOTECH that is just
BURNING through
FUNDS the way you say they are
Enjoy your Wk/end LT
they come and they go LOL
See how we go
(20min delay)